UP!
| 2016-06-02 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $60.00 to $84.00 |
| 2016-04-27 | Initiated Coverage | Barclays | Overweight | $85.00 |
| 2016-04-27 | Initiated Coverage | Barclays PLC | Overweight | $85.00 |
| 2016-02-24 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-02-19 | Lower Price Target | Citigroup Inc. | $128.00 to $91.00 | |
| 2016-01-27 | Reiterated Rating | Chardan Capital | Buy | |
| 2016-01-06 | Initiated Coverage | SunTrust | Buy | $100.00 |
| 2016-01-06 | Initiated Coverage | SunTrust Banks Inc. | Buy | $100.00 |
| 2015-12-04 | Reiterated Rating | Chardan Capital | Buy | |
| 2015-12-03 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | |
| 2015-11-19 | Reiterated Rating | Oppenheimer | Outperform | $95.00 |
| 2015-11-19 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $95.00 |
| 2015-11-17 | Reiterated Rating | Citigroup Inc. | Buy | |
| 2015-11-02 | Reiterated Rating | Oppenheimer | Outperform | $95.00 |
| 2015-10-27 | Reiterated Rating | Chardan Capital | Buy | $125.00 |
| 2015-09-30 | Reiterated Rating | Oppenheimer | Outperform | $95.00 |
| 2015-09-08 | Boost Price Target | Chardan Capital | Buy | $105.00 to $125.00 |
| 2015-09-03 | Initiated Coverage | Citigroup Inc. | Buy | $90.00 |
| 2015-08-16 | Initiated Coverage | Oppenheimer | Buy | |
| 2015-08-14 | Reiterated Rating | Oppenheimer | Outperform | $95.00 |
| 2015-08-07 | Downgrade | Goldman Sachs | Neutral to Sell | $45.00 |
| 2015-08-07 | Downgrade | Goldman Sachs Group Inc. | Neutral to Sell | $45.00 |
| 2015-08-06 | Reiterated Rating | Stifel Nicolaus | Buy | $74.00 to $83.00 |
| 2015-08-03 | Reiterated Rating | Chardan Capital | Buy | $105.00 |
| 2015-08-03 | Reiterated Rating | Leerink Swann | Outperform | $69.00 to $92.00 |
| 2015-07-07 | Initiated Coverage | Cowen and Company | Outperform | $80.00 |
| 2015-05-23 | Reiterated Rating | Stifel Nicolaus | Buy | $76.00 to $74.00 |
| 2015-05-23 | Reiterated Rating | Chardan Capital | Buy | $95.00 to $105.00 |
| 2015-05-12 | Lower Price Target | Stifel Nicolaus | Buy | $76.00 to $74.00 |
| 2015-05-12 | Boost Price Target | Chardan Capital | Buy | $95.00 to $105.00 |
| 2015-03-27 | Reiterated Rating | Chardan Capital | Buy | $85.00 to $90.00 |
| 2015-02-26 | Boost Price Target | Chardan Capital | Buy | $80.00 to $85.00 |
| 2015-02-24 | Boost Price Target | Leerink Swann | Outperform | $61.00 to $69.00 |
| 2015-02-24 | Boost Price Target | Stifel Nicolaus | Buy | $59.00 to $76.00 |
| 2015-02-18 | Initiated Coverage | Chardan Capital | Buy | $80.00 |
| 2015-02-10 | Reiterated Rating | Oppenheimer | Outperform | $95.00 |
| 2015-02-02 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $60.00 |
| 2014-12-16 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $51.00 to $60.00 |
| 2014-11-12 | Reiterated Rating | Stifel Nicolaus | Buy | $58.00 to $59.00 |
| 2014-07-25 | Initiated | Gabelli & Co | Buy | |
| 2014-07-25 | Initiated Coverage | Gabelli | Buy | $40.00 |
| 2014-07-25 | Initiated Coverage | Goldman Sachs | Neutral | $44.00 |
| 2014-07-17 | Boost Price Target | Leerink Swann | $45.00 to $61.00 | |
| 2014-07-07 | Initiated Coverage | Oppenheimer | Outperform | $95.00 |
| 2014-05-20 | Boost Price Target | Morgan Stanley | $79.00 to $99.00 | |
| 2014-05-20 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $40.00 to $51.00 |
| 2014-05-20 | Boost Price Target | Stifel Nicolaus | Buy | $55.00 to $58.00 |
| 2014-04-22 | Reiterated Rating | Morgan Stanley | Overweight | $79.00 |
| 2013-11-14 | Lower Price Target | Stifel Nicolaus | Buy | $52.00 to $49.00 |
| 2013-10-21 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $40.00 |
| 2013-10-21 | Initiated Coverage | Stifel Nicolaus | Buy | $52.00 |
| 2013-10-21 | Initiated Coverage | Morgan Stanley | Overweight | |
| 2013-10-21 | Initiated Coverage | Leerink Swann | Outperform | $37.00 |
| 2016-06-02 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $60.00 to $84.00 |
| 2016-04-27 | Initiated Coverage | Barclays | Overweight | $85.00 |
| 2016-04-27 | Initiated Coverage | Barclays PLC | Overweight | $85.00 |
| 2016-02-24 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-02-19 | Lower Price Target | Citigroup Inc. | $128.00 to $91.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In OPHT 16 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.42M |
| BlackRock Institutional Trust Company, N.A. | 0.77M |
| Apex Capital Management | 0.68M |
| EverPoint Asset Management, LLC | 0.45M |
| Numeric Investors LLC | 0.19M |
| BLACKROCK ADVISORS LLC | 0.19M |
| BlackRock Investment Management, LLC | 0.12M |
| MANAGED ACCOUNT ADVISORS LLC | 0.11M |
| Geduld E E | 50000 |
| KCG Holdings, Inc. | 48040 |
| BlackRock Group LTD | 23019 |
| Nine Chapters Capital Management LLC | 13500 |
| RUSSELL FRANK CO/ | 11717 |
| BlackRock Japan Co. Ltd | 3634 |
| MetLife Securities, Inc | 2037 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 9.38% (3139902) | OPHT / PTCT / TSPT / |
| SVLSF IV, LLC | 0.25% (84325) | OPHT / TRXC / |
| SBLENDORIO GLENN | 0.14% (48407) | FOLD / ICPT / MDCO / OPHT / |
| GUYER DAVID R Chief Executive Officer | 0.12% (38660) | OPHT / |
| Westby Keith SVP & COO | 0.07% (24983) | OPHT / |
| WOOD BARBARA A SVP,General Counsel,Secretary | 0.05% (16462) | GALE / OPHT / |
| PATEL SAMIR CHANDRAKANT President | 0.05% (15813) | OPHT / |
| Carroll David Francis SVP, CFO and Treasurer | 0.01% (4216) | OPHT / |
| GALAKATOS NICHOLAS | 0.01% (3945) | NSTG / OPHT / PTLA / RDUS / |
| ROSS MICHAEL JAY | 0.01% (3500) | OPHT / |
UM